Related Experiment Video
Updated: Aug 20, 2025

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Chronic Hepatitis B Virus and Hepatitis D Virus: New Developments
Ann Robinson1, Robert Wong2, Robert G Gish3
1California Pacific Medical Center, 1101 Van Ness Avenue, San Francisco, CA 94109, USA.
Insights
Hepatitis B virus (HBV) infection causes significant global deaths, primarily from cirrhosis and liver cancer. Increased vaccination and screening efforts are crucial for eradicating this preventable disease.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis B virus (HBV) and hepatitis D virus are major global health burdens, causing significant morbidity and mortality.
- Despite highly effective HBV vaccines (98%-100%), an estimated 820,000 deaths occurred in 2019, primarily due to cirrhosis and hepatocellular carcinoma.
- Disease prevalence is disproportionately high outside the United States, leading to underestimation of its impact.
Purpose of the Study:
- To highlight the ongoing global impact of Hepatitis B virus.
- To emphasize the need for enhanced public health strategies for HBV prevention and control.
- To advocate for expanded vaccination and screening measures to achieve disease eradication.
Main Methods:
- Review of global mortality data attributed to HBV.
- Analysis of vaccination efficacy and current public health recommendations.
- Assessment of disease sequelae, including cirrhosis and hepatocellular carcinoma.
Main Results:
- HBV remains a leading cause of preventable deaths worldwide.
- Cirrhosis and hepatocellular carcinoma are the primary sequelae driving mortality.
- Current vaccination strategies, while effective, have not eradicated the disease due to concentrated prevalence outside the US.
Conclusions:
- Expanded vaccination recommendations by the CDC are essential.
- Routine screening and heightened healthcare provider awareness are critical.
- A concerted public health approach is necessary to work towards the eradication of Hepatitis B virus.
Abstract:
Hepatitis B virus (HBV) and hepatitis D virus are leading causes of morbidity and mortality worldwide. Despite the availability of HBV vaccinations that are 98% to 100% effective, an estimated 820,000 annual deaths were attributed to HBV in 2019, mainly related to the sequelae of cirrhosis and hepatocellular carcinoma. Because disease prevalence is concentrated outside of the United States, it is overlooked, but with expanded vaccination recommendations provided by the Centers for Disease Control and Prevention and recommended screening, as well as heightened awareness by health care providers, we can work toward the eradication of this preventable disease.
Related Concept Videos
Viruses with RNA Genomes
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Retrovirus Life Cycles

